Pfizer vs. Moderna: Which Company's Booster Will Dominate?
Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) both are nearing the finish line with coronavirus booster shots. Big pharma Pfizer said just last week that it's ready to submit its candidate to regulators in the U.S., Europe, and elsewhere in a matter of weeks. Moderna previously has said its potential booster shot may be ready by fall.
The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention are saying fully vaccinated Americans don't need a booster shot right now. But with variants gaining ground, it seems clear these tools to jolt immunity higher may be necessary in the near future. Now, the big question is whether Pfizer or biotech rival Moderna will take the leading position in this new coronavirus market. Let's find out.
Image source: Getty Images.
Source Fool.com
